S

Sanofi

Global pharma company; vaccines and R&D

Area Business Manager - Sanofi Vaccines

Full-TimeDeadline 10/26/26
$100.5k - $145.2k/yr
Mid
Bachelor's
Chicago, IL, USA
HybridHybrid work is mentioned; the preferred residence is within the Arlington Heights territory.
Sales & Account ManagementField Sales

About the job

Requirements
  • A bachelor's degree.
  • A minimum of 3+ years of business-to-business sales experience, with preference for pharmaceutical, biotech, medical device, or other industries involving complex sales cycles and contracting opportunities.
  • Broad understanding of the healthcare environment, decision-making processes, and market trends, with a proven track record of accessing decision makers.
  • Skills and success within a business-to-business environment.
  • Strong commercial business acumen, strategic thinking, critical thinking, problem-solving, and innovative thinking capabilities.
  • Ability to navigate a hybrid environment and determine the optimal healthcare-professional selling model.
  • Ability to dynamically adjust priorities due to changing circumstances.
  • Ability to learn agilely and operate comfortably in complex environments.
  • Experience with omnichannel approaches and executing customer engagement through appropriate channels using insights.
  • Demonstrated ability to use data and data analytics to uncover valuable customer insights that can lead to new solutions.
  • Passion for science and proactive learning related to disease states, treatment options, and healthcare trends.
  • Ability to execute tactical initiatives, provide ongoing feedback, and prioritize multiple products.
  • Broad field sales experience with demonstrated success influencing decision makers.
  • Self-direction, organization, execution, and planning skills.
  • Excellent written and oral communication skills.
  • A valid driver's license, eligibility for insurance coverage, and the ability to safely operate a vehicle.
Responsibilities
  • Grow portfolio share and revenue and consistently deliver on product goals.
  • Act as a therapeutic area expert and position and differentiate products effectively.
  • Collaborate and coordinate with field-based stakeholders, including Medical Science Liaisons, Market Access teammates, strategic account managers, Hospital Business Managers, and others in the territory to address customer needs.
  • Identify market dynamics and trends, develop strategies supporting brand and corporate objectives, and ensure account success within the assigned geography.
  • Engage with account and territory data and work with internal data specialists to use insights that help healthcare professionals operate more effectively.
  • Determine the optimal Area Business Manager strategy for healthcare professionals using artificial intelligence and other digital tools.
  • Identify key opportunities and develop strategic business plans to generate product utilization and grow territory business.
  • Understand and differentiate portfolio contracting options and competitive offerings through financial presentations.
  • Perform according to a buy/bill model, including complex pricing analysis, price-calculator usage, product shipping, contract-compliance monitoring, and securing contract amendments.
  • Plan, organize, and execute local promotional speaker programs and activities.
  • Maximize the budget allocated to the geographic territory to support strategy execution and generate or grow the business.
  • Participate in and help lead initiatives supporting sales success, including industry-related congresses, local and regional meetings, and medical conferences.
Desired Qualifications
  • A graduate degree.
  • A minimum of 5+ years of pharmaceutical, biotech, or medical device sales experience with business-to-business experience.
  • At least 2 years of account-management experience.
  • Enhanced digital acumen.
  • Strong clinical acumen.
  • Experience working in Market Access, Pricing, Contracting, or Finance.
  • Proficiency with Microsoft Office and customer-management databases.

About the company

Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1973

Get referred to Sanofi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
  • June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
  • Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.

What critics are saying

  • Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
  • Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
  • Dupixent concentration makes 2030s patent loss an existential revenue shock.

What makes Sanofi unique

  • Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
  • October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
  • Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Parental Leave

Company News

Yahoo Finance
Oct 1st, 2026
Sanofi, Regeneron expand alliance in up to $8B deal for immunology drugs

France's Sanofi and US-based Regeneron Pharmaceuticals will expand their 20-year partnership to jointly develop and market immunology medicines in a deal worth up to $8 billion. Regeneron will receive $1 billion upfront, with potential additional payments of up to $7 billion tied to development, regulatory, and commercial targets. The collaboration will add four next-generation immunology drug candidates invented by Regeneron, with one currently in early-stage trials for eczema. The companies will equally share development costs and future profits from new drugs, whilst their existing profit-sharing agreement for top-selling medicine Dupixent remains unchanged. The deal settles prior litigation between the companies and marks an early move by Sanofi's new chief executive Belen Garijo to strengthen the company's pipeline.

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Vicebio

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes the acquisition of Dynavax

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...

U.S. Securities and Exchange Commission
Sep 20th, 2026
8-K

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)